Abstract
Bioresorbable vascular scaffolds (BRS), the newest coronary stent technology seems to be especially interesting treatment option in the setting of acute coronary syndromes(ACS). The study population consisted of the consecutive patients who underwent PCI with the Magmaris BRS in the settings of ACS
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
